Brevan Howard Capital Management’s AMERISAFE AMSF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$677K Sell
20,018
-6,062
-23% -$192K 0.01% 1282
2026
Q1
$869K Buy
26,080
+8,549
+49% +$308K 0.01% 982
2025
Q4
$673K Sell
17,531
-1,592
-8% -$64.2K 0.01% 949
2025
Q3
$838K Buy
+19,123
New +$857K ﹤0.01% 985
2024
Q4
Sell
-6,474
Closed -$313K 1022
2024
Q3
$313K Buy
6,474
+1,751
+37% +$83.3K ﹤0.01% 838
2024
Q2
$207K Buy
+4,723
New +$217K ﹤0.01% 880

Other funds holding AMSF

Brevan Howard Capital Management's AMSF Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its AMERISAFE (AMSF) stake by 23% in Q2 2026, selling an estimated $192K and leaving 20,018 shares worth $677K. The position accounts for 0.01% of the portfolio, ranked #1282.

Brevan Howard Capital Management first reported a position in AMSF in Q2 2024 and has held it in 6 quarters since. The position peaked at $869K in Q1 2026. 215 funds tracked by Wall St. Rank hold AMSF as of Q2 2026.

  • Brevan Howard Capital Management held 20,018 shares of AMERISAFE worth $677K as of Q2 2026.
  • Brevan Howard Capital Management sold 6,062 AMERISAFE shares in Q2 2026, an estimated $192K.
  • AMERISAFE made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1282 holding.
  • Brevan Howard Capital Management first reported a position in AMERISAFE in Q2 2024 and has held it in 6 quarters since.
  • Brevan Howard Capital Management's AMERISAFE position peaked at $869K in Q1 2026.
  • 215 funds tracked by Wall St. Rank held AMERISAFE as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.